Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
FTC to review Novo Holdings' Catalent buyout for another month
Despite a new 30-day extension on the FTC's review of Novo Holdings' Catalent buyout, the CDMO giant still expects the deal to close by year-end 2024.
Fraiser Kansteiner
May 3, 2024 2:00pm
Sponsored
MAIC Methodology Matters: Comparing BRUKINSA vs Acalabrutinib in R/R CLL
Apr 1, 2024 8:00am
Incyte's JAK cream Opzelura slows while Leo competition looms
May 3, 2024 10:53am
Merck's BCG monopoly could end
May 3, 2024 10:50am
GSK plays defense on call to pull popular children's asthma med
May 3, 2024 10:19am
Amid buzz for Amgen's obesity drug, company sees revenue boost
May 3, 2024 9:05am
Marketing News
Lilly catches Indiana Fever with jersey, health equity collab
May 2, 2024 2:07pm
Dupixent COPD delay possible, Eylea down 2%, Regeneron says
May 2, 2024 12:00pm
Blood test maker Mirvie debuts preeclampsia prevention toolkit
May 2, 2024 11:49am
Moderna plots launch of its next potential mRNA vaccine approval
May 2, 2024 11:08am
See More Marketing News